Carcinomas were at three clinical phases: We (n=19), II (n=6) and III (n=2). == Conclusions == These findings suggest that the antiproliferative effects of aglepristone in canine mammary carcinomas are mediated by progesterone receptor isoform A. == Electronic supplementary material == The online version of this article (doi:10.1186/s12917-014-0296-2) contains supplementary material, which is available to authorized users. Keywords:Canine mammary carcinoma, Progesterone receptor, Isoforms, Aglepristone, Hormone treatment == Background == Epidemiological and medical data show that progesterone offers proliferative effects on normal and neoplastic canine mammary epithelium [1]. Immunohistochemical (IHC) labelling at analysis has identified approximately two thirds of canine mammary carcinomas as progesterone receptor (PR) positive [2]. Moreover, neoadjuvant treatment with the antiprogestin aglepristone has been found to decrease cell proliferation in PR positive canine mammary carcinomas [3]. Aglepristone is currently used in medical practice to induce abortion and treat pyometra, as well in the treatment of proliferative progesterone-dependent diseases such as mammary fibroadenomatous hyperplasia in queens and vaginal tumours in bitches. Like its human being counterpart, canine PR is present as two isoforms: PR isoform A (PRA) and PR isoform B (PRB), which are transcribed from a single gene under the control of different promoters [4]. Under physiological conditions, normal human being breast cells expresses both PRA and PRB at equimolar levels EIF4EBP1 [5]. However, an modified PRA/PRB percentage is definitely often associated with breast carcinogenesis, PRA predominating over PRB in benign and malignant human being breast tumours [5]. Findings in dogs remain controversial, due to the paucity of study and the limited quantity of samples analysed. Western blot analysis of normal and tumoural mammary glands from six female dogs (two in metoestrus, two in anoestrus and two after long term treatment with progestins) showed that PRA was either equimolar or predominant in most samples, whereas predominance of PRB was recorded in only one case [4]. Moreover, the same technique offers exposed predominant staining for PRA with less intense staining for PRB in two normal canine mammary glands, three hyperplasias and three mammary carcinomas [6]. Despite their structural similarities, human being PRA and PRB have been shown to have different functions, in that they regulate different subsets of genes [7]. In human being breast tumor, VU6001376 carcinomas with higher levels of PRA than PRB were inhibited by antiprogestins, whereas carcinomas with high levels of PRB displayed no response to endocrine treatment [7]. Accordingly, it has been suggested the relative proportion of PR isoforms A and B might impact the prognosis and thus influence restorative decisions [5]. We VU6001376 have previously demonstrated that 1) neoadjuvant treatment with aglepristone decreases cell proliferation in PR positive carcinomas [3], and 2) PRA and PRB mRNA manifestation can be analysed in formalin-fixed, paraffin-embedded canine mammary gland cells samples by RT-qPCR [8]. This study wanted to examine the link between the effects of aglepristone within the proliferation index and mRNA manifestation of PRA and PRB in canine mammary carcinomas. IHC data of PR manifestation in the instances under study VU6001376 have been previously published [3]. == Methods == == Cells samples and VU6001376 medical data == Formalin-fixed paraffin-embedded (FFPE) cells samples from 27 canine mammary carcinomas were taken from 27 dogs randomly recruited between 2008 and 2010 for any pharmacodynamic study [3]. Dogs were aged 5 to 16, of both genuine (n = 14) and combined (n = 13) breeds, and at all phases of the oestrous cycle except oestrus (23 anoestrus, 3 dioestrus and 1 proestrus) as determined by vaginal cytology. Carcinomas were at three medical phases: I (n = 19), II (n = 6) and III (n = 2). None of the dogs experienced lung metastases (as determined by two thoracic radiographs). == Treatment protocol == All owners offered their educated consent for inclusion of their household pets.